542 related articles for article (PubMed ID: 2459997)
1. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
2. A rostrocaudal gradient for neurotransmitter metabolites and a caudorostral gradient for protein in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Whitmer B; Satjawatcharaphong C
Am J Vet Res; 1988 Dec; 49(12):2134-7. PubMed ID: 2467594
[TBL] [Abstract][Full Text] [Related]
3. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
Mignot E; Laude D; Elghozi JL
J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
[TBL] [Abstract][Full Text] [Related]
5. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
Eklundh T; Eriksson M; Sjöberg S; Nordin C
J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
[TBL] [Abstract][Full Text] [Related]
6. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C
Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887
[TBL] [Abstract][Full Text] [Related]
7. Monoamine metabolites in the CSF of conscious unrestrained cats.
Degrell I; Zenner K; Kummer P; Stock G
Brain Res; 1983 Oct; 277(2):283-7. PubMed ID: 6196083
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of DOPAC, MHPG, 5-HIAA and HVA in CSF by direct injection on a liquid chromatograph with coulometric detection.
d'Eril GV; Rizzo V; Cellerino GP
Funct Neurol; 1990; 5(2):145-9. PubMed ID: 1699850
[TBL] [Abstract][Full Text] [Related]
9. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
10. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
Poceta JS; Parsons L; Engelland S; Kripke DF
Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
[TBL] [Abstract][Full Text] [Related]
11. Effects of rat ovariectomy on CSF monoamine metabolite levels and elimination.
Duval C; Mignot E
J Neurochem; 1985 Apr; 44(4):1312-4. PubMed ID: 2579209
[TBL] [Abstract][Full Text] [Related]
12. Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus.
Pranzatelli MR; Huang YY; Tate E; Goldstein DS; Holmes CS; Goldstein EM; Ketner K; Kinast M; Lange BM; Sanz A; Shevell MI; Stanford RE; Taff IP
Mov Disord; 1998 May; 13(3):522-8. PubMed ID: 9613746
[TBL] [Abstract][Full Text] [Related]
13. [The effect of amino acids on neurotransmitter metabolites in the cerebrospinal fluid].
Zeman J; Böswart J
Cas Lek Cesk; 1991 May; 130(14):425-7. PubMed ID: 1712669
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical changes in pigeon cerebrospinal fluid during chronic administration of buspirone or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
Nader MA; Barrett JE
Pharmacol Biochem Behav; 1989 Jan; 32(1):227-32. PubMed ID: 2471984
[TBL] [Abstract][Full Text] [Related]
15. Role of neurotransmitter in forensic medicine (report II). A simple and simultaneous analysis of the major monoamine metabolites in human cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
Endo T; Nishida A; Kano S
Nihon Hoigaku Zasshi; 1987 Feb; 41(1):4-9. PubMed ID: 2439728
[No Abstract] [Full Text] [Related]
16. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
17. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
Endo T; Hara S; Kuriiwa F; Kano S
Forensic Sci Int; 1990 Jan; 44(1):61-8. PubMed ID: 1689267
[TBL] [Abstract][Full Text] [Related]
18. Hemiballismus: changes in cerebrospinal fluid.
Kostic V; Djuricic B; Paschen W
Acta Neurol Scand; 1988 Aug; 78(2):115-7. PubMed ID: 2459894
[TBL] [Abstract][Full Text] [Related]
19. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
Seifert WE; Foxx JL; Butler IJ
Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
[TBL] [Abstract][Full Text] [Related]
20. Stability of monoamine metabolites in human cerebrospinal fluid.
Langlais PJ; Bird ED; McEntee WJ
Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
